Moreover, A2M-inactivated proteolytic enzymes, including plasmin, urokinase-type plasminogen activators, and metalloproteases, have demonstrated involvement in the tumour invasion process [31,32,33]. The gene discussed is PLAU; the disease is neoplasm.